UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Onychomycosis: a review

Journal of the European Academy of Dermatology and Venereology, 2020-09, Vol.34 (9), p.1972-1990

2020

Volltextzugriff (PDF)

HLA-A31:01 and HLA-B15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children

Clinical pharmacology and therapeutics, 2013-07, Vol.94 (1), p.142-149

2013

Volltextzugriff (PDF)

Bruton tyrosine kinase inhibition warrants further study for pemphigus

British journal of dermatology (1951), 2021-10, Vol.185 (4), p.691-692

2021

Volltextzugriff (PDF)

Lymphomatoid papulosis: an update and review

Journal of the European Academy of Dermatology and Venereology, 2020-01, Vol.34 (1), p.59-73

2020

Volltextzugriff (PDF)

Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury

Clinical pharmacology and therapeutics, 2011-06, Vol.89 (6), p.896-901

2011

Volltextzugriff (PDF)

Tinea capitis in children: a systematic review of management

Journal of the European Academy of Dermatology and Venereology, 2018-12, Vol.32 (12), p.2264-2274

2018

Volltextzugriff (PDF)

Efficacy of non‐surgical treatments for androgenetic alopecia: a systematic review and network meta‐analysis

Journal of the European Academy of Dermatology and Venereology, 2018-12, Vol.32 (12), p.2112-2125

2018

Volltextzugriff (PDF)

Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study

British journal of dermatology (1951), 2014-06, Vol.170 (6), p.1341-1349

2014

Volltextzugriff (PDF)

Monotherapy for toenail onychomycosis: a systematic review and network meta‐analysis

British journal of dermatology (1951), 2020-02, Vol.182 (2), p.287-299

2020

Volltextzugriff (PDF)

Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome

British journal of dermatology (1951), 2007-11, Vol.157 (5), p.934-940

2007

Volltextzugriff (PDF)

Blistering severe cutaneous adverse reactions in children: proposal for paediatric‐focused clinical criteria

British journal of dermatology (1951), 2021-08, Vol.185 (2), p.447-449

2021

Volltextzugriff (PDF)

Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis

British journal of dermatology (1951), 2016-08, Vol.175 (2), p.422-424

2016

Volltextzugriff (PDF)

Pemphigus and associated comorbidities: a cross-sectional study

Clinical and experimental dermatology, 2015-08, Vol.40 (6), p.593-599

2015

Volltextzugriff (PDF)

The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis

Journal of the European Academy of Dermatology and Venereology, 2020-03, Vol.34 (3), p.580-588

2020

Volltextzugriff (PDF)

Long‐term 52‐week trends in apremilast safety outcomes for treatment of psoriasis in clinical practice: a multicentre, retrospective case series

British journal of dermatology (1951), 2019-01, Vol.180 (1), p.211-212

2019

Volltextzugriff (PDF)

A practical application of onychomycosis cure – combining patient, physician and regulatory body perspectives

Journal of the European Academy of Dermatology and Venereology, 2019-02, Vol.33 (2), p.281-287

2019

Volltextzugriff (PDF)

CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial

British journal of dermatology (1951), 2006-07, Vol.155 (1), p.170-181

2006

Volltextzugriff (PDF)

Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching‐adjusted indirect comparison

Journal of the European Academy of Dermatology and Venereology, 2019-06, Vol.33 (6), p.1107-1115

2019

Volltextzugriff (PDF)

Pseudotrichoscopic findings from colour product use: a retrospective analysis and a test to reproduce findings

Clinical and experimental dermatology, 2021-03, Vol.46 (2), p.360-362

2021

Volltextzugriff (PDF)

Assessing finasteride‐associated sexual dysfunction using the FAERS database

Journal of the European Academy of Dermatology and Venereology, 2017-06, Vol.31 (6), p.1069-1075

2017

Volltextzugriff (PDF)

Assessing dutasteride‐associated sexual dysfunction using the U.S. Food and Drug Administration Adverse Event Reporting System

Journal of the European Academy of Dermatology and Venereology, 2018-08, Vol.32 (8), p.1373-1376

2018

Volltextzugriff (PDF)

Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study

The Lancet (British edition), 2008-04, Vol.371 (9621), p.1337-1342

2008

Volltextzugriff (PDF)

Idiosyncratic drug reactions: the reactive metabolite syndromes

The Lancet (British edition), 2000-11, Vol.356 (9241), p.1587-1591

2000

Volltextzugriff (PDF)

Early‐stage mycosis fungoides screening investigations: a retrospective analysis of 440 cases

Journal of the European Academy of Dermatology and Venereology, 2018-06, Vol.32 (6), p.e217-e218

2018

Volltextzugriff (PDF)

Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations

Current oncology (Toronto), 2009, Vol.16 (1), p.16-26

2009

Volltextzugriff (PDF)

1 – 25 von 566

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(497)
Mit Volltextzugriff
(425)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(359)
Humans
(345)
Life Sciences & Biomedicine
(341)
Biological And Medical Sciences
(194)
Medical Sciences
(189)
Female
(186)
Male
(167)
Dermatology
(126)
Adult
(115)
Middle Aged
(111)
Pharmacology. Drug Treatments
(110)
Aged
(83)
Adolescent
(58)
Drug Toxicity And Drugs Side Effects Treatment
(55)
Pharmacology & Pharmacy
(48)
Child
(43)
General & Internal Medicine
(40)
Miscellaneous
(39)
Medicine, General & Internal
(35)
Treatment Outcome
(33)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Onychomycosis: a review

HLA-A31:01 and HLA-B15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children

Bruton tyrosine kinase inhibition warrants further study for pemphigus

Lymphomatoid papulosis: an update and review

Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury

Tinea capitis in children: a systematic review of management

Efficacy of non‐surgical treatments for androgenetic alopecia: a systematic review and network meta‐analysis

Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study

Monotherapy for toenail onychomycosis: a systematic review and network meta‐analysis

Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome

Blistering severe cutaneous adverse reactions in children: proposal for paediatric‐focused clinical criteria

Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis

Pemphigus and associated comorbidities: a cross-sectional study

The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis

Long‐term 52‐week trends in apremilast safety outcomes for treatment of psoriasis in clinical practice: a multicentre, retrospective case series

A practical application of onychomycosis cure – combining patient, physician and regulatory body perspectives

CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial

Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching‐adjusted indirect comparison

Pseudotrichoscopic findings from colour product use: a retrospective analysis and a test to reproduce findings

Assessing finasteride‐associated sexual dysfunction using the FAERS database

Assessing dutasteride‐associated sexual dysfunction using the U.S. Food and Drug Administration Adverse Event Reporting System

Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study

Idiosyncratic drug reactions: the reactive metabolite syndromes

Early‐stage mycosis fungoides screening investigations: a retrospective analysis of 440 cases

Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations

Suchergebnisse filtern